BIO.News Newsletter

It’s National Women’s Health Week, and we have a question: why is women’s health woefully underfunded? Meanwhile, Canada joins the U.S. in sensible regulation of gene-edited animal feed—leaving Mexico as the North American outlier. (597 words, 2 minutes, 59 seconds)

Today, the House Committee on Oversight and Accountability will mark up the amended BIOSECURE Act—we’ll be watching. Meanwhile, BIO explains why new AI patent guidance creates uncertainty and a North Carolina treasurer’s report calls out 340B abuses in the state. (592 words, 2 minutes, 57 seconds)

BIO and bipartisan policymakers highlighted how policy can support—or thwart—cancer innovation. Plus, BIO explains why a proposed federal rule should recognize the benefits of genetically engineered organisms (GEOs) to National Wildlife Refuges. (607 words, 3 minutes, 2 seconds)

BIO is leading the conversation this week on topics including adult vaccination and Mexico’s looming GM corn ban. (634 words, 3 minutes, 10 seconds)

The end of a busy week brings a new draft BIOSECURE Act—which takes into consideration BIO’s survey findings—and a plan to coordinate and streamline federal regulation of plants, animals, and microorganisms modified through biotechnology. (514 words, 2 minutes, 34 seconds)

Breaking: BIO has released the results of a survey revealing companies’ dependence on Chinese biomanufacturing. Yesterday, a busy day on Capitol Hill featured testimony from a BIO Board member and a reception celebrating the 20th anniversary of Project BioShield. (839 words, 4 minutes, 11 seconds)

A new platform highlights “one of the leading public health threats of our time” through powerful stories, while a report explores the health and occupational hazards of rising temperatures. Today, we’re watching BIO Board member Bill Newell, CEO of Sutro Biopharma, testify on Capitol Hill—stay tuned. (754 words, 3 minutes, 46 seconds)

BIO sets the record straight on accelerated approval—and experts answer YOUR questions about biotech, from how personalized medicine is shaping care to what makes startups attractive to investors. (641 words, 3 minutes, 12 seconds)

A new campaign seeks to #SaveBayhDole—plus, a few more things you need to know today, from D.C. to Texas to Mexico. (642 words, 3 minutes, 12 seconds)

In line with a BIO amicus brief, the California Supreme Court will consider Gilead’s request for summary dismissal of a lawsuit questioning its decisions about drug development. Plus, BIO applauds progress on the Farm Bill. (482 words, 2 minutes, 24 seconds)